Global NCD Funding | Global Heart | Volume 11, Issue 4, pp. 371-374
“The world has changed in the past decade, and the global health community is changing as well. Funding for diagonal approaches (sometimes called integration) is growing. People who care about nutrition now care about “malnutrition in all its forms”; people who pay for antiretroviral agents for patients living with human immunodeficiency virus and acquired immunodeficiency syndrome now want to prevent those same patients from dying of heart disease; people who care about economic development and jobs now focus on the productivity losses of premature illness and death; and people who care about poverty know that NCD are both the cause and consequence of poverty and must be slowed for Sustainable Development Goal #1 to succeed.”
Funding from the global community for noncommunicable disease (NCD) prevention and control in developing countries is miniscule—dwarfed by donor support for communicable diseases, maternal and child health, and other traditional health concerns in low-income countries. Yet, NCD now constitute the bulk of illness and deaths in low-income countries with, to date, only a small uptick in donor funding evident as a response. This paper describes recent magnitude and trends in the development of assistance for NCD; identifies the main sources among the 3 groupings of multilateral, bilateral, and private philanthropic funders; and discusses issues in tracking NCD donor funding, and challenges to mobilizing donor funding for NCD. Finally, it concludes with a more (slightly) optimistic outlook.
Link to full set of Global Heart Papers can be found here.